Early percutaneous tracheostomy in COVID19 patients with failed intubation: A case series

COVID19 and pulmonary dysfunction leading to acute respiratory distress syndrome (ARDS). Herein we presented the cases of failed intubation that was replaced by early percutaneous dilational tracheostomy. The procedure is safe for the patients, doctors and clinical staff. Additionally, we report mucormycosis after COVID19 treatment that was potentially due to immunosuppressive drugs. •Systemic manifestation of COVID19 and pulmonary dysfunction leading to ARDS.•Early tracheostomy after 48 hours of initial intubation, protective measures and vaccine injection.•COVID19 patients should be critically monitored for opportunistic infections.